GAITHERSBURG, Md., Jan. 05, 2022 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to…
Super UserJanuary 7, 2022
DUBLIN--(BUSINESS WIRE)--Jan. 6, 2022-- Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has signed a long-term, full-building lease with…
Super UserJanuary 7, 2022
ROCKVILLE, Md., Jan. 6, 2022 /PRNewswire/ -- Potential one-time gene therapy for the treatment of Duchenne includes a novel, optimized…
Super UserJanuary 7, 2022
Maryland biotech company Zalgen Labs has moved to Frederick, illustrating the magnetism of the biotech hub for leaders like its own Dr. Luis…
Super UserJanuary 5, 2022
Imagine you’re working outside and accidentally cut your foot on a protruding stick you didn’t see. No big deal. You…
Super UserJanuary 5, 2022
On this snowy start to 2022, I wanted to share with you two interviews with AHEAD100 Chief Scientist Dr. James…
Super UserJanuary 4, 2022
BioHealth Innovation (BHI) is an innovation intermediary that facilitates the commercialization of emerging technologies in the BioHealth Capital Region (Maryland,…
Super UserJanuary 3, 2022
Global health tech companies are queueing up for one of the world’s largest in-person events of the New Year- CES…
Super UserJanuary 3, 2022
Two-dose primary regimen of NVX-CoV2373 demonstrated cross-reactive immune responses against Omicron (B.1.1.529) and other variants Third dose produced increased immune…
Super UserJanuary 3, 2022